The Parkinson's and Movement Disorders Center
Southfield, Michigan, United States
Neurologist in Royal Oak, Michigan
3555 W 13 Mile Rd Suite N120, Royal Oak, MI 48073
About The Parkinson's and Movement Disorders Center
"Our clinic offers opportunities to participate in research, including clinical trials, genetic studies, and neuroimaging. We provide an interdisciplinary approach that includes neurologist, neurosurgeons, physical therapists, speech therapists and other medical team members. We specialize in evaluating and treating patients with Parkinson's disease, Huntington's chorea, ataxia, Tourette's syndrome, tremors, dystonia, torticollis, restless leg syndrome."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at The Parkinson's and Movement Disorders Center
During the past decade, The Parkinson's and Movement Disorders Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer
1999-03-01
2007-04-01
Completed
Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer
2000-10-01
Unknown status
Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer
2002-06-01
Unknown status
Determination of Carboplatin's Optimal Plasmatic Exposure
2005-05-01
2009-02-01
Completed
400
Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer
2005-09-01
Completed
835
Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST)
2009-01-01
2018-07-01
Terminated
335
Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis
2010-04-01
2014-12-01
Completed
183
Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents
2011-10-01
2014-02-01
Completed
2,114
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at The Parkinson's and Movement Disorders Center
According to Clinical.Site data, the most researched conditions in "The Parkinson's and Movement Disorders Center" are
"Cervical Dystonia" (2 trials). Many other conditions were trialed in "The Parkinson's and Movement Disorders Center" in a lesser frequency.
Clinical Trials Intervention Types at The Parkinson's and Movement Disorders Center
Most popular intervention types in "The Parkinson's and Movement Disorders Center" are "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Botulinum toxin type A" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The Parkinson's and Movement Disorders Center
The vast majority of trials in "The Parkinson's and Movement Disorders Center" are
2 trials for "All" genders.
Clinical Trials Status at The Parkinson's and Movement Disorders Center
Currently, there are NaN active trials in "The Parkinson's and Movement Disorders Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in The Parkinson's and Movement Disorders Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in The Parkinson's and Movement Disorders Center, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".